MX2010005545A - Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca. - Google Patents
Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca.Info
- Publication number
- MX2010005545A MX2010005545A MX2010005545A MX2010005545A MX2010005545A MX 2010005545 A MX2010005545 A MX 2010005545A MX 2010005545 A MX2010005545 A MX 2010005545A MX 2010005545 A MX2010005545 A MX 2010005545A MX 2010005545 A MX2010005545 A MX 2010005545A
- Authority
- MX
- Mexico
- Prior art keywords
- heart failure
- prophylaxis
- treatment
- oxazolidinones
- disorders related
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere al uso de inhibidores selectivos del factor de coagulación Xa, en particular de oxazolidinonas de la fórmula (I), para el tratamiento y/o profilaxis de la insuficiencia cardiaca y/o trastornos relacionados con la insuficiencia cardiaca así como a su uso para la preparación de fármacos para el tratamiento y/o profilaxis de la insuficiencia cardiaca y/o trastornos relacionados con la insuficiencia cardiaca.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US740607P | 2007-12-11 | 2007-12-11 | |
PCT/EP2008/010211 WO2009074249A1 (en) | 2007-12-11 | 2008-12-03 | Oxazolidinones for the treatment and/or prophylaxis of heart failure |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010005545A true MX2010005545A (es) | 2010-07-30 |
Family
ID=40404481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005545A MX2010005545A (es) | 2007-12-11 | 2008-12-03 | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20110003804A1 (es) |
EP (1) | EP2229173A1 (es) |
JP (1) | JP2011506363A (es) |
KR (1) | KR20110010689A (es) |
CN (1) | CN101896185A (es) |
AU (1) | AU2008335922A1 (es) |
BR (1) | BRPI0820964A2 (es) |
CA (1) | CA2708418C (es) |
DO (1) | DOP2010000156A (es) |
IL (1) | IL205675A (es) |
MA (1) | MA31902B1 (es) |
MX (1) | MX2010005545A (es) |
NZ (1) | NZ586002A (es) |
RU (2) | RU2494740C2 (es) |
SV (1) | SV2010003578A (es) |
TN (1) | TN2010000266A1 (es) |
UA (1) | UA99638C2 (es) |
WO (1) | WO2009074249A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2459555T1 (sl) * | 2009-07-31 | 2022-03-31 | Krka, D.D., Novo Mesto | Postopek kristalizacije rivaroksabana |
CN103626749A (zh) * | 2012-08-21 | 2014-03-12 | 苏州泽璟生物制药有限公司 | 取代的噁唑烷酮化合物和包含该化合物的药物组合物及其用途 |
WO2018234308A1 (en) * | 2017-06-20 | 2018-12-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | METHODS FOR IDENTIFYING IF PATIENTS WITH ACUTE CARDIAC DISEASE FAILURE (ICAD) HAVE A HYPERCOAGULABLE CONDITION |
JP7376873B2 (ja) * | 2017-11-09 | 2023-11-09 | 国立大学法人 東京医科歯科大学 | がん促進因子発現抑制剤、その有効成分のスクリーニング方法、該方法に有用な発現カセット、診断薬、及び診断方法 |
JP6574041B2 (ja) * | 2017-12-15 | 2019-09-11 | エルメッド株式会社 | リバーロキサバン含有医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3176626B2 (ja) * | 1991-11-01 | 2001-06-18 | ファルマシア・アンド・アップジョン・カンパニー | 抗菌剤として有用な置換アリール−およびヘテロアリールフェニルオキサゾリジノン類 |
DK0623615T3 (da) * | 1993-05-01 | 1999-12-13 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
PE20080183A1 (es) * | 2006-04-06 | 2008-03-10 | Schering Corp | Terapias de combinacion de tra |
-
2008
- 2008-12-03 JP JP2010537292A patent/JP2011506363A/ja active Pending
- 2008-12-03 WO PCT/EP2008/010211 patent/WO2009074249A1/en active Application Filing
- 2008-12-03 AU AU2008335922A patent/AU2008335922A1/en not_active Abandoned
- 2008-12-03 CA CA2708418A patent/CA2708418C/en not_active Expired - Fee Related
- 2008-12-03 RU RU2010128442/15A patent/RU2494740C2/ru not_active IP Right Cessation
- 2008-12-03 UA UAA201008619A patent/UA99638C2/ru unknown
- 2008-12-03 NZ NZ586002A patent/NZ586002A/en not_active IP Right Cessation
- 2008-12-03 BR BRPI0820964-2A patent/BRPI0820964A2/pt not_active IP Right Cessation
- 2008-12-03 KR KR1020107012797A patent/KR20110010689A/ko not_active Application Discontinuation
- 2008-12-03 CN CN2008801209375A patent/CN101896185A/zh active Pending
- 2008-12-03 US US12/746,661 patent/US20110003804A1/en not_active Abandoned
- 2008-12-03 MX MX2010005545A patent/MX2010005545A/es active IP Right Grant
- 2008-12-03 EP EP08860784A patent/EP2229173A1/en not_active Withdrawn
-
2010
- 2010-05-11 IL IL205675A patent/IL205675A/en unknown
- 2010-05-25 DO DO2010000156A patent/DOP2010000156A/es unknown
- 2010-05-26 SV SV2010003578A patent/SV2010003578A/es unknown
- 2010-06-08 MA MA32895A patent/MA31902B1/fr unknown
- 2010-06-09 TN TN2010000266A patent/TN2010000266A1/fr unknown
-
2013
- 2013-07-22 RU RU2013134140/15A patent/RU2013134140A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UA99638C2 (ru) | 2012-09-10 |
IL205675A0 (en) | 2010-11-30 |
MA31902B1 (fr) | 2010-12-01 |
NZ586002A (en) | 2012-06-29 |
DOP2010000156A (es) | 2011-02-15 |
TN2010000266A1 (en) | 2011-11-11 |
US20110003804A1 (en) | 2011-01-06 |
WO2009074249A1 (en) | 2009-06-18 |
IL205675A (en) | 2013-10-31 |
KR20110010689A (ko) | 2011-02-07 |
RU2013134140A (ru) | 2015-01-27 |
BRPI0820964A2 (pt) | 2015-07-14 |
EP2229173A1 (en) | 2010-09-22 |
JP2011506363A (ja) | 2011-03-03 |
RU2010128442A (ru) | 2012-01-20 |
AU2008335922A1 (en) | 2009-06-18 |
CA2708418C (en) | 2013-11-12 |
CN101896185A (zh) | 2010-11-24 |
CA2708418A1 (en) | 2009-06-18 |
RU2494740C2 (ru) | 2013-10-10 |
SV2010003578A (es) | 2011-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0625648D0 (en) | Compounds | |
IN2012DN01233A (es) | ||
MX337575B (es) | Compuestos de sulfona y métodos para lafabricación y uso de éstos. | |
HK1146485A1 (es) | ||
MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
MY147994A (en) | Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors | |
MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
UA105036C2 (uk) | Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії | |
MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
NO20082120L (no) | Behandling og forebyggelse av mikroangiopati | |
NO20091655L (no) | Substituerte dihydropyrazoloner for behandling av kardiovaskulaere og hematologiske sykdommer | |
MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
PT2222669E (pt) | Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p) | |
NO20084328L (no) | Nye forbindelser | |
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
EA201201658A1 (ru) | Производные пиперидина и их применение для лечения метаболических нарушений | |
JO2645B1 (en) | Vehicles | |
MY150931A (en) | Substituted oxazolidinones and their use | |
TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
BRPI0911678B8 (pt) | maleato de orvepitant cristalino anidro, composição farmacêutica compreedendo o dito maleato e uso do mesmo para o tratamento ou profilaxia de doenças do sistema nervoso central | |
TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
PD | Change of proprietorship |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH |